Infants in Sandwell are screened for haemoglobinopathy gene

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7069.1403b (Published 30 November 1996) Cite this as: BMJ 1996;313:1403
  1. Jammi N Rao (jammi@bharat.demon.co.uk),
  2. Sunil I Handa,
  3. Penelope J Stableforth,
  4. Jackie Martin,
  5. Helen Watson,
  6. Glenda Augustine
  1. Consultant in public health Sandwell Health Authority, West Bromwich B71 4NA
  2. Consultant haematologist Consultant haematologist Haematology department manager Biomedical scientist Haemogobinopathy clinical nurse specialist Sandwell Healthcare NHS Trust, West Bromwich B71 4HJ

    EDITOR,—Linda Laird and colleagues are right in stating that it is important to cater for the needs of families with infants who are found to be carriers of a haemoglobinopathy gene.1 We believe that families should be fully informed when a screening programme detects a heterozygous carrier infant.

    Since 1992 we have run a selective newborn screening programme in Sandwell (population 295 000; a quarter of births are to couples in which one or both …

    View Full Text

    Sign in

    Log in through your institution